Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from Korea

被引：6
|
作者：
Hahn, Seung Min [1 ,2 ]
Han, Jung Woo [1 ,2 ]
Kim, Jin Seok [3 ]
Shim, Ye Jee [4 ]
Kim, Soyon [5 ]
Kim, Hugh Chul [5 ]
Park, Young Shil [6 ]
Lyu, Chuhl Joo [1 ,2 ,7 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Dept Pediat Hematol Oncol,Coll Med, Seoul, South Korea
[3] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[4] Keimyung Univ, Dongsan Hosp, Dept Pediat, Sch Med, Daegu, South Korea
[5] Kim & Lees Internal Med Clin, Seoul, South Korea
[6] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Pediat, Coll Med, Seoul, South Korea
[7] Yonsei Univ, Severance Hosp, Coll Med, Yonsei Canc Ctr,Dept Pediat Hematol Oncol, 50-1 Yonseiro, Seoul 03722, South Korea
来源：
HAEMOPHILIA | 2023年 / 29卷 / 04期
关键词：
PROPHYLAXIS;
D O I：
10.1111/hae.14819
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1163 / 1166
页数：4
相关论文
共 50 条
  • [1] Real-world data on the use of emicizumab in patients with haemophilia A with and without inhibitors in Singapore
    Lee, Ming Wei
    Cheong, May Anne
    Ng, Heng Joo
    Tien, Sim Leng
    Lam, Joyce Ching Mei
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (11) : 580 - 589
  • [2] Real-world experience with the use of emicizumab in paediatric haemophilia A patients with and without inhibitors
    Lam, Joyce Ching Mei
    Lim, Chiew Ying
    Kadir, Nur Insyirah Abdul
    HAEMOPHILIA, 2022, 28 : 50 - 51
  • [3] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2021, 27 : 70 - 70
  • [4] REAL-WORLD SAFETY AND EFFICACY OF EMICIZUMAB IN HAEMOPHILIA A WITH INHIBITORS IN THE UK
    Wall, C.
    Hall, G.
    Scott, M.
    Collins, P. W.
    Maclean, R.
    Xiang, H.
    Hay, C. R.
    Hart, D. P.
    Anderson, J.
    Dolan, G.
    Symington, E.
    HAEMOPHILIA, 2020, 26 : 64 - 65
  • [5] REAL-WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Wall, C.
    Xiang, H.
    Palmer, B.
    Collins, P. W.
    Stephensen, D.
    Scott, M.
    Chalmers, E.
    Chowdary, P.
    Hall, G. W.
    Liesner, R.
    Hart, D. P.
    Shapiro, S.
    Talks, K.
    Fletcher, S.
    Hay, C. R.
    HAEMOPHILIA, 2021, 27 : 116 - 116
  • [6] Real-World Use of Emicizumab in Patients with Hemophilia with and without Inhibitors
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Ballester, Lance
    Raffini, Leslie J.
    BLOOD, 2019, 134
  • [7] Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Ballester, Lance
    Raffini, Leslie
    HAEMOPHILIA, 2020, 26 (04) : 631 - 636
  • [8] Real-world cost estimates of initiating emicizumab in US patients with haemophilia A
    Samelson-Jones, Benjamin J.
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Raffini, Leslie
    HAEMOPHILIA, 2021, 27 (04) : 591 - 598
  • [9] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [10] Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China
    Huang, Kun
    Liu, Guoqing
    Wu, Runhui
    Chen, Zhenping
    Zhen, Yingzi
    Wu, Xinyi
    HAEMOPHILIA, 2022, 28 : 50 - 50
12345